Hepatitis C in childhood

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 4, 2002, Pages 476-481

  Hardikar, Winita ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Breast feeding; Cesarean section; Children; Clinical outcome; Diagnosis of HCV; HCV infection; Hepatitis C; Liver biopsy; Maternal transmission; Neonatal infection; Risk factors; Treatment

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; HEPATITIS A VACCINE; HEPATITIS B VACCINE; HEPATITIS C VACCINE; RIBAVIRIN; VIRUS RNA;

ASIA; AUSTRALIA; BLOOD EXAMINATION; BLOOD TRANSFUSION; BREAST FEEDING; BREAST MILK; CESAREAN SECTION; CHEMOTHERAPY; CHILDHOOD; CHILDHOOD DISEASE; CHRONIC DISEASE; CONFERENCE PAPER; DECISION MAKING; DISEASE COURSE; DISEASE SEVERITY; DISEASE TRANSMISSION; DRUG INDUCED DISEASE; EXTRACORPOREAL OXYGENATION; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; INFECTION PREVENTION; LIVER CIRRHOSIS; LIVER FIBROSIS; MEDICAL PRACTICE; PEDIATRICIAN; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SCREENING; VIRUS TRANSMISSION;

EID: 0036091693     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2002.02731.x     Document Type: Conference Paper

References (47)

1. Neonatal and post-transfusion hepatitis C: A look back and a look forward
2. Prevalence of hepatitis G/GBV-C viraemia in a healthy paediatric population
3. Prevalence of antibody to hepatitis C virus in Japanese school children: Comparison with adult blood donors
4. Minimal role of hepatitis C virus infection in childhood liver diseases in an area hyperendemic for hepatitis B infection
5. Hepatitis C virus infection in different groups of children in Wuhan area
6. The risk of transmitting HCV, HBV or HIV by blood transfusion in Victoria
7. Hepatitis C virus infection
8. Risk of hepatitis C infection in neonates transfused with blood from donors infected with hepatitis C
9. Hepatitis C infection in children who received extracorporeal membrane oxygenation
10. Transfusion-acquired hepatitis C virus infection in a Canadian population, October 1983 through June 1985
11. Sexual and non-sexual intrafamilial spread of hepatitis C virus: Intrafamilial transmission of HCV
12. Prevalence of hepatitis C virus in family members of patients with hepatitis C
13. Intrafamilial transmission of hepatitis C virus
14. Hepatitis C virus infection in the mothers and infants cohort study
15. Hepatitis C infection in children - A Melbourne perspective
16. Post-transfusion and community-acquired hepatitis C in childhood
17. Natural history of chronic viral hepatitis in childhood
18. Post-transfusion chronic hepatitis in children
19. Antibody-negative chronic hepatitis C virus infection in immunocompetent children
20. Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection
21. Chronic hepatitis C in children: The pathological and clinical spectrum
22. Histopathology of the liver in children with chronic hepatitis C viral infection
23. Chronic hepatitis C in children: A clinical and immunohistochemical comparative study with adult patients
24. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening
25. Long-term mortality and morbidity of transfusion associated non-A, non-B, and type C hepatitis: A national heart, lung and blood institute collaborative study
26. Performance of three generations of anti-hepatitis C virus enzyme-linked immunosorbent assays in donors and patients
27. Hepatitis C-role of perinatal transmission
28. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C
29. Mother-to-child transmission of hepatitis C virus: Evidence for preventable peripartum transmission
30. Pathological and virological findings in patients with persistent hypertrans-aminasaemia of unknown aetiology
31. Long term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon
32. Favourable response to lymphoblastoid interferon-alpha in children with chronic hepatitis C
33. Interferon-alpha treatment of chronic hepatitis C virus infection in children
34. Lymphoblastoid interferon alpha treatment in chronic hepatitis C
35. Interferon-alpha and ribavirin treatment of hepatitis C in children with malignancy in remission
36. Safety, efficacy and pharmacokinetics of interferon alpha -2b and ribavirin in children with chronic hepatitis C
37. Interferon therapy reduces the risk for hepatocellular carcinoma: National surveillance program of cirrhotic and non-cirrhotic patients with chronic hepatitis C in Japan
38. Cost effectiveness analysis of different strategies of management of chronic hepatitis C infection in children
39. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatits C
40. A review of hepatitis C virus (HCV) vertical transmission: Risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection
41. Mother to child transmission of hepatitis C virus: Prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1
42. Role of breast-feeding in transmission of hepatitis C virus to infants of HCV-infected mothers
43. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis
44. The impact of diagnosis of hepatitis C virus on quality of life
45. Health-related quality of life in chronic hepatitis C: Impact of disease and treatment response
46. Side-effects of alpha-interferon therapy and impact on health-related quality of life in children with chronic viral hepatitis
47. Health-related quality of life in children with hepatitis C acquired in the first year of life